Has Katie Wadlington, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,282 in general payments to Katie Wadlington, MD across 251 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Katie Wadlington, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Katie Wadlington, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Katie Wadlington, MD

Dermatology · Fort Smith, ARNPI 1417445180

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.9% of the total across 251 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations.

$6,282in general payments, 2019–2025

Across 251 payments — averaging $25.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$974
AbbVie$724
Dermavant Sciences, Inc.$628
Lilly USA, LLC$597
E.r. Squibb & Sons, L.L.C.$513
Johnson & Johnson$365
plus $2K from 17 others

What the payments were for

Food & beverage$6,21099%
Education$721%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	20	$974
AbbVie	33	$724
Dermavant Sciences, Inc.	16	$628
Lilly USA, LLC	29	$597
E.r. Squibb & Sons, L.L.C.	19	$513
Johnson & Johnson	22	$365
Regeneron Healthcare Solutions, Inc.	12	$346
Amgen	13	$317
UCB, Inc.	11	$306
Novartis	15	$294
Incyte Corporation	14	$276
Sun Pharmaceutical Industries Inc.	12	$250
LEO Pharma Inc.	7	$154
Arcutis Biotherapeutics, Inc.	7	$153
Pfizer	5	$90
Botanix SB Inc	4	$72
Galderma Laboratories, L.p.	3	$58
Mayne Pharma Commercial LLC	2	$41
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$40
Kerecis Limited	2	$29
Convatec Inc.	1	$25
Organogenesis Inc.	1	$19
Genentech USA, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VTAMA$422
DUPIXENT$147
Sotyktu$125

How this compares

$6,282 in reported general payments places this provider in the 70th percentile of 75 dermatology providers in Arkansas.

See all dermatology providers in Arkansas →

Medicare billing

Part B allowed, 2024

$274,044

Medicare patients

592

Services billed

3,046

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	24	$96,856
Tacrolimus	33	$3,009
Fluorouracil	39	$2,239
Betamethasone Dipropionate	76	$2,020
Triamcinolone Acetonide	173	$1,992
Clobetasol Propionate	72	$1,843
Cephalexin	244	$1,609
Ketoconazole	121	$1,602
Metronidazole	16	$1,408
Doxycycline Hyclate	125	$1,165
Mupirocin	93	$704
Dutasteride	32	$478
Hydrocortisone	35	$455
Mometasone Furoate	17	$244
Clindamycin Hcl	31	$217

Paid to pharmacies, not to this prescriber.

Other dermatology in Fort Smith

Sandra JohnsonFort Smith$543K
Phillip StitesFort Smith$15K
Chelsea MeltzerFort Smith$11K
George LewisFort Smith$6K
Sara LambFort Smith$3K
Arjun SainiFort Smith$2K
Cyril SevernsFort Smith$950
Scott JacksonFayetteville$533K
Mildred CliftonBentonville$92K
Lance HenryFayetteville$39K

See the full list for Arkansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →